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ORIGINAL ARTICLE

Coronavirus Disease 2019 (COVID-19)
Pandemic Shifts Inpatient Imaging
Utilization
Jason J. Naidich, MD, MBA a,b,d , Artem Boltyenkov, PhD, MBA c,e, Jason J. Wang, PhD d,
Jesse Chusid, MD, MBA f,g, Danny Hughes, PhD h,i, Pina C. Sanelli, MD, MPH d, f, j
Abstract
Objective: The coronavirus disease 2019 (COVID-19) pandemic has had a signiﬁcant impact on imaging utilization across practice
settings. The purpose of this study was to quantify the change in the composition of inpatient imaging volumes for modality types and
Current Procedural Terminology–coded groups during the COVID-19 pandemic.
Methods: A retrospective study of inpatient imaging volumes in a large health care system was performed, analyzing weekly imaging
volumes by modality types (radiography, CT, MRI, ultrasound, interventional radiology, nuclear medicine) in years 2020 and 2019.
The data set was split to compare pre-COVID-19 (weeks 1-9) and post-COVID-19 (weeks 10-16) periods. Further subanalyses
compared early post-COVID-19 (weeks 10-13) and late post-COVID-19 (weeks 14-16) periods. Statistical comparisons were performed using c2 and independent-samples t tests.
Results: Compared with 2019, total inpatient imaging volume in 2020 post-COVID-19, early and late post-COVID-19 periods,
declined by 13.6% (from 78,902 to 68,168), 16.6% (from 45,221 to 37,732), and 9.6% (from 33,681 to 30,436), respectively. By
week 16, inpatient imaging volume rebounded and was only down 4.2% (from 11,003 to 10,546). However, a statistically signiﬁcant
shift (P < .0001) in the 2020 composition mix was observed largely comprised of radiography (74.3%), followed by CT (12.7%),
ultrasound (8%), MRI (2.4%), interventional radiology (2.3%), and nuclear medicine (0.4%). Although the vast majority of imaging
studies declined, few Current Procedural Terminology–coded groups showed increased trends in imaging volumes in the late postCOVID-19 period, including CT angiography chest, radiography chest, and ultrasound venous duplex.
Discussion: During the COVID-19 pandemic, we observed a decrease in inpatient imaging volumes accompanied by a shift away from
cross-sectional imaging toward radiography. These ﬁndings could have signiﬁcant implications in planning for a potential resurgence.
Key Words: COVID-19, CPT-coded examinations, imaging volume, inpatient service, modality types
J Am Coll Radiol 2020;-:---. Copyright ª 2020 American College of Radiology

INTRODUCTION
The coronavirus disease 2019 (COVID-19) pandemic continues to signiﬁcantly impact the health of the population,

affecting a total of 1,859,693 people in the United States with
106,927 deaths as of June 2, 2020 [1]. New York state
quickly became the US epicenter of COVID-19 disease,
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with 380,825 cases and 29,988 deaths [1] occurring in a
short period of time. Hospitals had to become ﬂexible to
quickly expand inpatient units and provide appropriate
resources for this rapidly growing cohort. Additionally, this
novel disease population posed a challenge for health care
providers to anticipate the necessary resources because new
information about disease progression and complications
was continually becoming available.
As medical resources shifted away from elective and
nonurgent procedures toward emergent and critical care of
patients with COVID-19, departments were forced to reconﬁgure their personnel and resources. In particular, many radiology practices rescheduled nonurgent and routine imaging
according to recommendations from the ACR [2]. Hence,
radiology practices experienced signiﬁcant declines in imaging
volumes, especially in the outpatient setting [3,4]. Although,
the inpatient setting was not as severely affected by declines
in imaging volumes, a shift was observed in the composition
mix of imaging modality types with increased use of
radiography relative to cross-sectional imaging [4]. These
ﬁndings suggest a potential impact on the resource utilization,
stafﬁng needs, and reimbursement for radiology practices.
The purpose of this study was to evaluate the change in
the inpatient imaging volumes and composition mix during
the COVID-19 pandemic. We analyzed the weekly imaging
volumes stratiﬁed by the imaging modality types and Current Procedural Terminology (CPT)-coded examination
groups during the COVID-19 pandemic in a large health
care system.

METHODS
A retrospective review of the inpatient imaging case volumes
in a large integrated health care system [4] was performed
from January 1, 2019, to April 18, 2020, to evaluate the
change in the imaging volumes and composition mix
according to imaging modality types and CPT-coded examination groups during the COVID-19 pandemic. Similar
to our prior methods [4], the weekly aggregated imaging
volumes were provided in 2020 and 2019 for the
inpatient service stratiﬁed by the imaging modality types
(radiography, ultrasound, CT, MRI, nuclear medicine,
and interventional radiology). Individual CPT-coded data
within each modality type were also provided as weekly
aggregated data to further evaluate the case volumes for
speciﬁc types of imaging examinations. Overall, there was
no signiﬁcant decline in the number of imaging scanners in
our health care system between 2020 and 2019 that could
have potentially affected the expected imaging examination
volumes during the COVID-19 pandemic. Institutional
review board approved a waiver to use the retrospective
aggregate data.
2

At our institution, the ﬁrst patient testing positive for
COVID-19 was conﬁrmed on March 8, 2020 (week 11, day
1). However, the ﬁrst patient testing positive for COVID19 was conﬁrmed on March 1, 2020 (week 10, day 1), in
New York City. On March 27, 2020 (week 13, day 6), the
radiology department released guidelines for inpatient imaging utilization to limit the spread of the coronavirus (severe acute respiratory syndrome coronavirus 2) to health
care providers, staff, and patients, as well as to reduce
contamination of imaging equipment from scanning patients with COVID-19 [4].

Statistical Analysis
The 2020 and 2019 aggregated weekly (weeks 1-16) imaging case volumes were stratiﬁed by imaging modality types
(radiography, ultrasound, CT, MRI, nuclear medicine, and
interventional radiology) and by individual CPT codes. For
the analysis of the CPT-coded data, CPT groups were primarily assigned by anatomic regions (such as head; orbit,
face, or neck; chest; abdomen or pelvis; and extremities)
within each modality type. Noninvasive vascular imaging
was assigned as separate CPT-coded groups according to the
modality types and anatomic regions, such as CT angiography (CTA) head and MR angiography head. E-only
Supplemental Tables S1 to S6 in the online Supplemental
Materials show the categorization of the individual CPT
codes into the speciﬁc groups used in the analysis.
The data set was split for analysis to compare the preCOVID-19 (weeks 1-9) and post-COVID-19 (weeks 1016) periods. Further subanalyses of the post-COVID-19
period was performed by splitting the data set into the
early post-COVID-19 (weeks 10-13) period representing
the transition phase during the rapid inpatient inﬂux of
patients with COVID-19 and the late post-COVID-19
(weeks 14-16) period representing the inpatient imaging
volumes during the height of the pandemic. The 2019 week
1 (5 days) aggregate imaging volume was adjusted to reﬂect
the same 4 days of imaging volume acquired in 2020 by
removing 1 day of the average daily volume calculated in
week 1 from the data analysis for similar comparisons.
The weekly imaging volumes were plotted for weeks 1
to 16 for the total inpatient imaging volume and stratiﬁed
by imaging modality types and CPT-coded groups for both
2020 and 2019 to demonstrate the trends in service volumes. The number of services performed was aggregated for
the total weeks 1 to 16, pre-COVID-19 and post-COVID19 periods, and early and late post-COVID-19 periods according to the imaging modality types in 2020 and 2019.
The 2020 percent difference in the total inpatient imaging
volumes was calculated compared with 2019 for the total
weeks 1 to 16, pre-COVID-19 and post-COVID-19
Journal of the American College of Radiology
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periods, early and late post-COVID-19 periods, and week
16. In these analyses, the same weeks in the 2020 and 2019
calendar years were compared with account for monthly or
seasonal variation. The composition mix of the 2020 total
imaging volume according to modality types during the late
post-COVID-19 (weeks 14-16) period was compared with
2019. The c2 test was used to assess statistical signiﬁcance
among categorical variables between 2020 and 2019.
For each modality type, the mean weekly imaging case
volumes were calculated for the total weeks 1 to 16, preCOVID-19 and post-COVID-19 periods, and early and
late post-COVID-19 periods. The 2020 and 2019 mean
weekly imaging volumes for each modality type were
compared using independent-samples t tests for the total
weeks 1-16, early post-COVID-19 (weeks 10-13), and late
post-COVID-19 (weeks 14-16) periods. Additionally, the
mean weekly imaging case volumes for each modality type
were compared for the pre-COVID-19 (weeks 1-9) and
post-COVID-19 (weeks 10-16) periods in 2020 and 2019
separately to assess statistical signiﬁcance of the change in
the post-COVD-19 period within the same calendar year.
Further analyses were performed comparing the 2020 and
2019 mean weekly imaging case volumes for speciﬁc imaging examinations by CPT-coded groups during the late
post-COVID-19 (weeks 14-16) period. P < .05 determined
statistical signiﬁcance. SAS version 9.4 (SAS, Cary, North
Carolina) was used for all statistical analyses.

RESULTS
In 2020, the total inpatient imaging volume performed at
our institution for weeks 1 to 16 was 162,470 examinations,

Table 1. Comparison of the 2020 and 2019 total inpatient
imaging case volumes stratiﬁed by time periods

Time Periods

2020

2019

2020 Percent
Difference

Weeks 1-16

162,470 175,511

7.4

Pre-COVID-19
(weeks 1-9)

94,302

96,609

2.4

Post-COVID-19
(weeks 10-16)

68,168

78,902

13.6

Early post-COVID-19 37,732
(weeks 10-13)

45,221

16.6

Late post-COVID-19
(weeks 14-16)

30,436

33,681

9.6

Week 16

10,546

11,003

4.2

COVID ¼ coronavirus disease 2019.
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compared with 175,511 examinations in 2019, representing
an overall 7.4% decline. Table 1 shows the comparison of
the 2020 and 2019 total inpatient imaging volume
stratiﬁed by time periods for the total weeks 1 to 16, preCOVID-19 (weeks 1-9) and post-COVID-19 (weeks 1016) periods, early post-COVID-19 (weeks 10-13) and late
post-COVID-19 (weeks 14-16) periods, and week 16.
Overall, the 2020 inpatient imaging volume during the
post-COVID-19 (weeks 10-16) period declined by 13.6%
(from 78,902 to 68,168) compared with 2019. However,
when further analyzing the post-COVID-19 period, a
greater decline of 16.6% (from 45,221 to 37,732) was
observed in the 2020 early post-COVID-19 (weeks 10-13)
period. In the late post-COVID-19 (weeks 14-16) period,
the 2020 inpatient imaging volume had a smaller decline of
9.6% (from 33,681 to 30,436). By week 16, the inpatient
imaging volume only declined by 4.2% (from 11,003 to
10,546) compared with 2019. Figure 1 reveals the trends in
the 2020 and 2019 total inpatient imaging volume across
weeks 1 to 16. The 2020 total inpatient imaging volume
began to decline in week 10 (when the ﬁrst patient testing
positive for COVID-19 was conﬁrmed in New York
City). However, total imaging volume started to increase in
week 14, resulting in a smaller decline in the late postCOVID-19 (weeks 14-16) period.
Table 2 compares the mean weekly imaging volumes
according to modality types for the total weeks 1 to 16 in
years 2020 and 2019. There was a statistically signiﬁcant
decline in the inpatient mean weekly imaging volumes for
CT (264.3, P ¼ .035), MRI (175.0, P ¼ .012),
interventional radiology (106.4, P ¼ .002), and nuclear
medicine (59.7, P ¼ .001). Although the imaging
volumes for radiography and ultrasound declined in 2020,
it was not statistically signiﬁcant. Figure 2 demonstrates
the trends in the imaging volumes in years 2020 and
2019 across weeks 1 to 16 stratiﬁed by imaging modality
types. In the early post-COVID-19 (weeks 10-13) period,
the 2020 imaging case volumes declined across all modality
types. In the late post-COVID-19 (weeks 14-16) period,
increased inpatient imaging volumes are seen for all modality types, except nuclear medicine.
Table 3 compares the mean weekly imaging volumes for
the pre-COVID-19 (weeks 1-9) and post-COVID-19
(weeks 10-16) periods according to modality types in both
2020 and 2019 separately. In 2019, there was no statistically
signiﬁcant change in the inpatient imaging volumes by
modality types in weeks 10 to 16 (post-COVID-19 group)
compared with weeks 1 to 9 (pre-COVID-19 group). In
2020, there was a statistically signiﬁcant decline in the imaging volumes during the post-COVID-19 (weeks 10-16)
period for CT (490.0, P ¼ .013), MRI (312.0, P ¼
.004), ultrasound (453.4, P ¼ .007), interventional
3

Fig 1. The 2020 and 2019 inpatient imaging case volume trends across weeks 1 to 16 including all imaging modality types
(radiography, CT, MRI, ultrasound, interventional radiology, and nuclear medicine). The vertical red line at week 10 indicates
when the ﬁrst patient testing positive for coronavirus disease 2019 (COVID-19) was conﬁrmed in New York City. The vertical
black line at week 14 indicates the late post-COVID-19 (weeks 14-16) period. Calendar weeks are presented on the x axis and
number of imaging examinations on the y axis.

radiology (110.6, P ¼ .032), and nuclear medicine
(85.6, P ¼ .001), compared with the pre-COVID-19
(weeks 1-9) period. However, radiography imaging volume
increased (þ711.9, P ¼ .176) during the post-COVID-19
period but was not statistically signiﬁcant.
Table 4 compares the 2020 and 2019 mean weekly
imaging volumes in the early post-COVID-19 (weeks 1013) and late post-COVID-19 (weeks 14-16) periods stratiﬁed by the modality types. In the early post-COVID-19
period, the 2020 imaging volumes show a statistically signiﬁcant decline compared with 2019 for only nuclear

Table 2. Comparison of the 2020 and 2019 inpatient
mean weekly imaging case volumes for the total weeks
1-16 stratiﬁed by imaging modality types
Imaging
Modality

2020,
Mean (SD)

CT

1,777.8 (414.3)

MRI

577.9 (235.0)

Ultrasound

1,257.6 (360.5)

2019,
Mean (SD)

P
Value

2,042.1 (225.4) .0349*
752.9 (94.1)

.0120*

1,447.0 (164.5) .0697

Interventional

369.9 (105.3)

476.3 (58.9)

.0018*

Nuclear
medicine

123.9 (59.0)

183.6 (24.1)

.0013*

Radiography
*P < .05.
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6,047.3 (1,023.6) 6,067.6 (704.7) .9481

medicine (79.0, P ¼ .022). However, in the late postCOVID-19 period, the 2020 imaging volumes for all modality types had statistically signiﬁcant declines, except for
radiography (þ1,328.7, P ¼ .0002), which had a statistically signiﬁcant increased imaging volume. Figure 3
compares the 2020 and 2019 composition mix of the
inpatient imaging volumes by modality types for the late
post-COVID-19 (weeks 14-16) period to further understand the shift in imaging utilization. There is a statistically
signiﬁcant change (P < .0001) in the composition mix of
the 2020 imaging volumes during the late post-COVID-19
period largely comprised of radiography (74.3%), followed
by CT (12.7%), ultrasound (8%), MRI (2.4%), interventional radiology (2.3%), and nuclear medicine (0.4%).
Table 5 compares the 2020 and 2019 mean weekly
imaging volumes during the late post-COVID-19 (weeks
14-16) period for each modality type stratiﬁed by CPTcoded groups. There was a shift in the imaging volumes
by speciﬁc imaging examinations. For example, within the
CT modality type, all CPT-coded groups signiﬁcantly
declined (P < .05) in 2020 compared with 2019, except for
CTA chest (þ96.7, P ¼ .176), which showed increased
volume in 2020 (although not statistically signiﬁcant). A
similar pattern is seen in the radiography modality with
increased volume for radiography chest (þ267.3, P ¼ .064)
in the 2020 late post-COVID-19 period. Within the ultrasound modality, venous duplex (75.6, P ¼ .315)
declined in the 2020 late post-COVID-19 period compared
with 2019; however, this was not statistically signiﬁcant.
Journal of the American College of Radiology
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Fig 2. The 2020 and 2019 inpatient imaging case volume trends across weeks 1 to 16 stratiﬁed by imaging modality types.
The vertical red line at week 10 indicates when the ﬁrst patient testing positive for coronavirus disease 2019 (COVID-19) was
conﬁrmed in New York City. The vertical black line at week 14 indicates the late post-COVID-19 (weeks 14-16) period.
Calendar weeks are presented on the x axis and number of imaging examinations on the y axis.

Ultrasound head (þ5.3, P ¼ .592), ultrasound chest (4.7,
P ¼ .124), MRI cardiac (3.3, P ¼ .100), and MR angiography abdomen or pelvis (1.7, P ¼ .279) were not
statistically changed in the late post-COVID-19 period,
likely because of the small sample size in each group.
Figure 4 shows the 2020 and 2019 imaging case volume
trends across weeks 1 to 16 for CTA chest, ultrasound
venous duplex, and radiography chest, demonstrating the
increased imaging volumes in the 2020 late post-COVID19 (weeks 14-16) period compared with the early postCOVID-19 (weeks 10-13) period.

DISCUSSION
In a short time, the COVID-19 pandemic has had a substantial economic impact on health care institutions. Many
radiology practices experienced a rapid decline in imaging case
Journal of the American College of Radiology
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volumes [3,4] as a consequence of public policy, ﬁnancial
hardship, and patient fear. In particular, outpatient imaging
was expected to have the greatest decline in imaging
volumes across all modality types [4]. Even though inpatient
imaging was less affected by the declines in imaging volume
during the post-COVID-19 (weeks 10-16) period, it is
important to be aware that there was a signiﬁcant shift in the
composition mix of the imaging modality types and speciﬁc
CPT-coded examinations.
The results from this study revealed an overall 13.6%
decline in the total imaging volume in the inpatient setting
over the ﬁrst 7-week period during the COVID-19
pandemic, compared with 2019, including all imaging
modality types. For further analysis of the post-COVID-19
(weeks 10-16) period, the data set was split to represent the
early post-COVID-19 (weeks 10-13) and late post5

Table 3. Comparison of the inpatient mean weekly imaging case volumes for the pre-COVID-19 (weeks 1-9) and
post-COVID-19 (weeks 10-16) periods in years 2020 and 2019 stratiﬁed by imaging modality types
2020 Weeks 1-9,
Mean (SD)

2020 Weeks 10-16,
Mean (SD)

P
Value

2019 Weeks 1-9,
Mean (SD)

CT

1,992.1 (297.0)

1,502.1 (392.4)

.0129*

2,019.8 (297.6)

2,070.7 (85.0)

.6361

MRI

714.4 (121.4)

402.4 (233.4)

.0037*

722.0 (113.1)

792.7 (42.4)

.1130

1,456.0 (241.2)

1,002.6 (335.2)

.0070*

1,413.6 (213.6)

1,490.0 (54.8)

.3286

Interventional

418.3 (81.5)

307.7 (104.2)

.0316*

455.4 (71.8)

503.0 (17.8)

.0873

Nuclear
medicine

161.3 (31.8)

75.7 (50.3)

.0010*

177.1 (157.2)

191.9 (20.3)

.2371

Radiography

5,735.8 (926.6)

6,447.7 (1,068.6)

.1755

5,946.4 (919.3)

6,223.4 (254.1)

.4096

Imaging
Modality

Ultrasound

2019 Weeks 10-16,
P
Mean (SD)
Value

COVID ¼ coronavirus disease 2019.
*P < .05.

COVID-19 (weeks 14-16) periods. There was a greater
decline of 16.6% in the total inpatient imaging volume
during the early post-COVID-19 period immediately after
the ﬁrst patient testing positive for COVID-19 was
conﬁrmed in New York City (week 10, day 1). This may be
partly explained by the preemptive response to lower the
overall inpatient census by delaying elective procedures to
increase capacity for the expected inﬂux of patients with
COVID-19. However, the inpatient imaging volume
increased in the late post-COVID-19 (weeks 14-16) period,
resulting in only a 9.6% decline in year-over-year imaging
volume, likely due to the surge of patients with COVID-19
requiring hospitalization. By week 16, the inpatient imaging
volume was down only 4.2% compared with the same
period in 2019.

Despite the relatively modest level of inpatient imaging
volume decline compared with the outpatient and emergency settings [4], this study revealed that the 2020 imaging
volume composition mix changed signiﬁcantly (P < .0001)
during the COVID-19 pandemic. A signiﬁcant shift in the
imaging modality types was observed in the 2020 late postCOVID-19 (weeks 14-16) period with the greatest percentage comprised of radiography (74.3%), followed in
descending order by CT (12.7%), ultrasound (8.0%), MRI
(2.4%), interventional radiology (2.3%), and nuclear medicine (0.4%). This may be partly explained by the departmental guidelines recommending judicious use of crosssectional imaging, ultrasound, and interventional radiology
to prevent spread of COVID-19 disease to patients and
health care providers.

Table 4. Comparison of the 2020 and 2019 inpatient mean weekly imaging case volumes for the early post-COVID-19
(weeks 10-13) and late post-COVID-19 (weeks 14-16) periods stratiﬁed by imaging modality types
Imaging
Modality

2020 Weeks 10-13, 2019 Weeks 10-13,
P
2020 Weeks 14-16, 2019 Weeks 14-16,
Mean (SD)
Mean (SD)
Value
Mean (SD)
Mean (SD)
P Value

CT

1,659.8 (431.0)

2,075.3 (101.7)

.1480

1,292.0 (259.5)

2,064.7 (77.9)

.0078*

MRI

525.8 (245.0)

821.3 (32.0)

.0937

238.0 (49.5)

754.7 (8.1)

<.0001*

1,146.5 (379.2)

1,485.8 (69.4)

.1708

810.7 (157.3)

1,495.7 (41.2)

.0019*

Interventional

364.3 (103.7)

503.3 (22.7)

.0720

232.3 (39.1)

502.7 (13.4)

.0003*

Nuclear
medicine

106.0 (46.9)

185.0 (21.8)

.0224*

35.3 (4.9)

201.0 (17.3)

<.0001*

Radiography

5,630.8 (445.0)

6,234.8 (339.5)

.0743

7,537.0 (117.0)

6,208.3 (142.4)

.0002*

Ultrasound

COVID ¼ coronavirus disease 2019.
*P < .05.
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Fig 3. The 2020 and 2019 inpatient imaging volume composition mix stratiﬁed by modality types during the late postcoronavirus disease 2019 (COVID-19; weeks 14-16) period. A statistically signiﬁcant shift (P < .0001) in the 2020 imaging
composition mix (n ¼ 30,436) was observed compared with 2019 (n ¼ 33,681). Speciﬁcally, the 2020 imaging volumes for
CT, MRI, ultrasound (US), interventional radiology (IR), and nuclear medicine (NM) decreased compared with 2019. However,
the 2020 imaging volume for radiography (XR) increased representing almost three-quarters of all imaging performed.

When we further examined the speciﬁc CPT-coded
groups within imaging modality types during the 2020
late post-COVID-19 (weeks 14-16) period, we found that
the mean weekly imaging volumes statistically declined for
all CPT-coded groups in CT and radiography modality
types, except for CTA chest and radiography chest,
compared with 2019. The imaging volumes actually
increased for CTA chest and radiography chest in the late
post-COVID-19 period, although this change was not statistically signiﬁcant. In addition, the 2020 trend data
revealed an increase in the imaging volumes in the late postCOVID-19 (weeks 14-16) period for CTA chest, radiography chest, and ultrasound venous duplex, relative to the
early post-COVID-19 (weeks 10-13) period. From the
growing literature in this area, we are now aware that
changes in the prothrombotic factors occur in severe
COVID-19 infection inducing a hypercoagulable state
[5,6]. These patients have been reported with elevated Ddimer, ﬁbrinogen, and factor VIII [5,6], with marked
increased frequency of venous thromboembolism and
pulmonary embolism seen in up to one-third of patients
with COVID-19 in the intensive care unit [7,8]. The
imaging workup for the diagnosis of these clinical
manifestations includes radiography chest, CTA chest, and
ultrasound venous duplex, likely explaining the shift in the
imaging composition mix observed in this study.
To our knowledge, no prior publications have evaluated
the change in the inpatient imaging volumes and composition mix during the COVID-19 pandemic stratiﬁed by
imaging modality types and CPT-coded groups. The results
from this study may have signiﬁcant implications for leaders
preparing for a potential resurgence of the COVID-19 crisis.
Journal of the American College of Radiology
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These real-world data should be useful in preparing for
potential resource utilization and stafﬁng requirements. In
particular, these results may be helpful in developing new
imaging utilization guidelines and departmental policies
aimed at optimally accommodating the unique imaging
needs for patients with COVID-19. Radiology practices can
plan in advance for adequate stafﬁng, as well as develop safe
and efﬁcient decontamination procedures in speciﬁc imaging modalities (radiography, ultrasound, and CT). Additionally, radiologists with clinical expertise for the speciﬁc
CPT-coded imaging examinations (radiography chest,
CTA chest, and ultrasound venous duplex) will be valuable
in providing high-quality care.
The main limitations of this study are similar to our
prior work [4] using a retrospective study design analyzing
aggregated and anonymized data. However, this study
provided more detailed analyses of individual CPT-coded
groups within each modality type. Within the ultrasound
modality, point-of-care ultrasound was excluded in the
aggregated volume data. Although another limitation
affecting the generalizability of these ﬁndings is that our
health care system is located in the epicenter of the COVID19 pandemic [4], these results may be helpful in establishing
a worst-case scenario. Further studies evaluating the inpatient imaging volumes and composition mix in radiology
practices located outside the epicenter would also be a
valuable addition to the literature.
In summary, the results from this study provide realworld data to inform radiology practices regarding not
only the decline in inpatient imaging volumes but more
importantly the signiﬁcant shift in the imaging composition
mix during the COVID-19 pandemic. This study may assist
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Table 5. Comparison of the 2020 and 2019 inpatient mean weekly imaging case volumes for the late post-COVID-19 (weeks
14-16) period stratiﬁed by CPT-coded groups
2020

2019

Imaging Modality CPT-Coded Groups

Mean

SD

Mean

SD

P Value

CT
Head
Orbit, face, or neck
Spine
Extremities
Abdomen or pelvis
Chest
Head or neck
Chest
Abdomen or pelvis
Cardiac

393.3
11.7
36.7
26.6
228.7
195.3
51.0
227.0
18.7
4.3

64.9
4.9
8.1
4.2
48.0
11.1
16.1
101.8
3.8
3.2

552.7
34.7
73.7
68.3
471.3
395.0
83.3
130.3
40.0
18.7

25.0
9.1
8.1
9.3
24.4
17.7
9.2
2.3
8.7
5.7

.0375*
.0293*
.0050*
.0075*
.0045*
.0002*
.0392*
.1756
.0357*
.0292*

MRI
Brain
Spine
Abdomen or pelvis
Extremities
Cardiac
Head
Neck
Abdomen or pelvis

111.0
42.7
23.7
10.0
1.7
15.0
7.0
1.3

24.2
16.8
2.3
2.6
0.6
3.6
1.7
1.2

300.3
154.3
81.0
59.7
5.0
63.0
40.7
3.0

8.6
6.8
4.4
6.7
2.6
5.6
5.8
2.0

.0025*
.0030*
.0002*
.0023*
.1000
.0006*
.0060*
.2794

Ultrasound
Neck
Pelvis
Head
Chest
Abdomen
Obstetrics
Extremities
Spine
Vascular (arterial)
Venous duplex

3.7
14.3
41.3
2.0
257.0
6.0
4.0
4.7
33.0
314.7

1.5
1.2
15.3
2.6
29.5
2.0
2.6
0.6
9.6
112.6

18.3
42.7
36.0
6.7
537.7
16.7
16.7
3.3
177.3
390.3

2.5
9.9
4.4
3.2
15.5
2.1
3.1
0.6
5.0
19.7

.0023*
.0366*
.5921
.1242
.0007*
.0031*
.0059*
.0474*
<.0001*
.3154

Interventional

268.3

57.5

509.0

40.3

.0057*

Nuclear medicine
Pulmonary
Other

9.0
18.0

2.6
3.6

28.7
105.0

3.1
20.0

.0012*
.0148*

Radiography
Chest
Spine
Other bones
Abdomen
Head or neck
Fluoroscopy

4,726.0
9.0
148.3
202.0
1.0
12.3

113.2
8.2
19.6
21.0
0
3.2

4,458.7
77.0
689.0
480.3
6.0
149.7

142.4
10.1
72.3
24.6
1.7
19.6

.0636
.0010*
.0037*
.0001*
.0377*
.0056*

COVID ¼ coronavirus disease 2019; CPT ¼ Current Procedural Terminology.
*P < .05.
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Fig 4. The 2020 and 2019 inpatient imaging case volume trends across weeks 1 to 16 for CT angiography (CTA) chest,
ultrasound venous duplex, radiography chest (left column). The trend data for the respective imaging modality type including
all other Current Procedural Terminology codes are displayed for comparison (right column). The vertical red line at week 10
indicates when the ﬁrst patient testing positive for coronavirus disease 2019 (COVID-19) was conﬁrmed in New York City. The
vertical black line at week 14 indicates the late post-COVID-19 (weeks 14-16) period. Calendar weeks are presented on the x
axis and number of imaging examinations on the y axis.

in guiding inpatient practice decisions based on the shift in
the imaging volumes across different modality types and
speciﬁc CPT-coded groups to provide optimal access and
availability of the imaging resources necessary during the
COVID-19 pandemic.

-

Imaging volume deterioration varied in the postCOVID-19 (weeks 10-16) period with the greatest
decline (16.6%) observed in the early post-COVID19 (weeks 10-13) period. Inpatient imaging volume
started to increase in the late post-COVID-19 (weeks
14-16) period. By week 16, the inpatient imaging
volume only declined by 4.2%.

-

A statistically signiﬁcant shift in the 2020 imaging
volume composition mix was observed in the late
post-COVID-19 (weeks 14-16) period, largely
comprised of radiography (74.3%), followed by CT

TAKE-HOME POINTS
-

This study revealed an overall 13.6% decline in the
inpatient imaging volume during the COVID-19
pandemic (7 weeks) including all imaging modality
types.
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(12.7%), ultrasound (8%), MRI (2.4%), interventional radiology (2.3%), and nuclear medicine (0.4%).
-

The trend data revealed increased imaging volumes
for speciﬁc CPT-coded groups in the late
post-COVID-19 (weeks 14-16) period for CTA chest,
radiography chest, and ultrasound venous duplex.

-

These data may be useful to radiology practices in
preparing for the possibility of a second wave of the
COVID-19 pandemic.
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